Literature DB >> 9352865

Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.

P Sauer1, L Theilmann, W Stremmel, C Benz, G M Richter, A Stiehl.   

Abstract

BACKGROUND & AIMS: In patients with cirrhosis of the liver, after the first variceal bleeding episode, transjugular intrahepatic portosystemic stent shunting (TIPS) and endoscopic sclerotherapy plus propranolol (ES) were compared regarding prevention of variceal rebleeding and mortality.
METHODS: Eighty-three patients with cirrhosis of the liver were randomized to undergo TIPS (n = 42) or ES (n = 41).
RESULTS: Median observation time was in 1.6 years in the TIPS group and 1.45 years in the ES group. Cumulative rates of rebleeding were 23% in the TIPS group and 57% in the ES group (P = 0.0001). Hepatic encephalopathy was observed in 29% of the patients in the TIPS group and in 13% of those in the ES group (P = 0.041). Cumulative rates of survival were 69% in the TIPS group and 67% in the ES group (P = 0.62). Mortality rates in both groups were positively correlated with a higher Child's classification.
CONCLUSIONS: Although TIPS significantly reduced the rate of rebleeding, survival rates were not improved. Because TIPS is associated with an increased risk of encephalopathy and high rates of shunt dysfunction, which requires reintervention, the procedure cannot be recommended for elective treatment after the first variceal bleeding episode, but it is an effective therapy in patients in whom endoscopic sclerotherapy fails to control bleeding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352865     DOI: 10.1053/gast.1997.v113.pm9352865

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

Review 1.  TIPSS 10 years on.

Authors:  R Jalan; H F Lui; D N Redhead; P C Hayes
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

2.  UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology.

Authors:  R Jalan; P C Hayes
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

3.  Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.

Authors:  G Pomier-Layrargues; J P Villeneuve; M Deschênes; B Bui; P Perreault; D Fenyves; B Willems; D Marleau; M Bilodeau; M Lafortune; M P Dufresne
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

Review 4.  Transjugular portosystemic stent shunt in treatment of liver diseases.

Authors:  M Schepke; T Sauerbruch
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 5.  Current status of transjugular intrahepatic portosystemic shunts.

Authors:  N H Patel; N Chalasani; R M Jindal
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

6.  Percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization for the treatment of variceal bleeding and hypersplenism.

Authors:  Wei-Dong Gong; Ke Xue; Yuan-Kui Chu; Qing Wang; Wei Yang; Hui Quan; Peng Yang; Zhi-Min Wang; Zhi-Qun Wu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  Octreotide followed by sclerotherapy was not more effective than emergency injection sclerotherapy for acute variceal haemorrhage.

Authors:  A Burroughs
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

Review 8.  Current use of transjugular intrahepatic portosystemic shunts.

Authors:  Timothy M McCashland
Journal:  Curr Gastroenterol Rep       Date:  2003-02

9.  Direct intrahepatic portacaval shunt: an experimental study.

Authors:  Jian-Jun Luo; Zhi-Ping Yan; Kang-Rong Zhou; Sheng Qian
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

10.  Interventional radiology in the management of portal hypertension.

Authors:  Sundeep J Punamiya
Journal:  Indian J Radiol Imaging       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.